GENE ONLINE|News &
Opinion
Blog

2017-11-03|

November 3, 1950: American Biochemist James Rothman was Born

by GeneOnline
Share To

James Rothman (November 3, 1950 – present) is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University and the Chairman of the Department of Cell Biology at Yale School of Medicine. Rothman dedicates his career in studying intracellular and extracellular vesicles and the trafficking mechanism. Rothman had a great contribution in discoverying how the sac-like structures within and between cells precisely transport hormones, growth factors, and other molecules to correlated destination. Rothman jointly received the 2013 Nobel Prize in Physiology or Medicine with Randy Schekman and Thomas C. Südhof for their work on vesicle trafficking. He has also received many other honors, including the King Faisal International Prize in 1996, the Louisa Gross Horwitz Prize from Columbia University and the Albert Lasker Award for Basic Medical Research both in 2002.

Reference

https://www.nobelprize.org/nobel_prizes/medicine/laureates/2013/rothman-bio.html https://en.wikipedia.org/wiki/James_Rothman

Image Source

http://fmri.org/commentary/

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top